• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Bora to Expand Rare Disease Portfolio with Acquisition of Pyros

    PRESS RELEASE

    Pyros Pharmaceuticals Launches VIGAFYDE, Ready-to-Use Vigabatrin Solution

    BUSINESSWIRE

    Pyros Pharma Abstract Accepted For Poster At AES 2024 Annual Meeting

    BUSINESSWIRE

    Pyros Pharma`s Vigafyde (vigabatrin) Receives Approval in the U.S

    FDA

    Pyros Pharmaceuticals Announces FDA Approval of VIGAFYDE™

    BIOSPACE

    Pyros Pharms New Vigabatrin Receives Approval in US

    FDA

    Pyros Pharma Announces FDA Approval Of VIGAFYDE™ Oral Solution

    BUSINESSWIRE

    Pyros Pharmaceuticals Announces VIGPODER™ (vigabatrin) is Now Available

    BUSINESSWIRE

    Pyros Announces Positive Outcome of the Procedure for Approval of VIGZIP

    BUSINESSWIRE

    Pyros Pharmaceuticals’ Abstract Accepted for Poster Presentation

    BUSINESSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.